Shots:

• Takeda has entered into a five-year agreement with Accenture and Amazon Web Services (AWS) to support the company in moving 80% of its applications to the cloud and modernizing its research tools
• The transition of Takeda’s applications to the cloud will enable the company to remove non-differentiating technology and create a scalable architecture. The collaboration will leverage cloud and data-driven insights to accelerate drug development- increase operational agility- reduce technology costs- and develop the workforce of the future
• Additionally- the collaboration with Accenture and AWS has already helped the Takeda to use the cloud in launching a clinical trial acceleration and secure data-sharing platform for the COVID R&D Alliance in <5days. The COVID R&D Alliance is a consortium comprising 20 companies- including Takeda- Amgen- and AbbVie to study and identify the potential of COVID-19 therapies
  
    Ref: Takeda | Image: Enterprise Talk